Tamoxifen possible treatment for myeloproliferative neoplasms

Researchers at the National Center for Cardiovascular Research (CNIC) in Spain found that estrogens play a role in regulating the active of blood stem cells from bone marrow. Simon Mendez-Ferrer, Jürg Schwaller and Radek Skoda published a paper in Cell which demonstrated that tamoxifen - an approved breast cancer drug - was effective in blocking the symptoms and progression of myeloproliferative neoplasms.

Cell publication

Receive updates on the latest MPN news & events.

Find out ways you can help support MPN patients and researchers.

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe